Moderna Inc, whose vaccine has also been authorized for emergency use in the United States, had said on Monday it would test a new booster shot aimed at the South African variant of the coronavirus after concluding the antibody response could be diminished.
Pfizer did not immediately respond to a Reuters request for comment.